ICD-11中孤独症谱系障碍的批判性反思:对临床实践与研究的潜在影响
本文为观点文章,比较ICD-11与DSM-5对孤独症谱系障碍(ASD)的概念化方式。作者认为ICD-11允许高度多样的症状组合,可能导致ASD操作化定义偏向极端异质性而牺牲精确性,对临床实践、照护和研究产生不可预知的影响。文章建议采用更精确的定量描述和更客观的症状测量来定义临床ASD表型。
要点
- ICD-11允许高度多样的症状组合,使ASD操作化定义偏向极端异质性而可能牺牲精确性。
- ICD-11的ASD概念难以与其他精神障碍及孤独症样特质区分,临床实用性存疑。
- 该概念包含许多模糊主观概念,导致不可证伪的诊断,存在假阳性诊断和患病率进一步升高的风险。
核心结论
- ICD-11对ASD的概念化允许高度多样的症状组合,可能牺牲精确性,对临床实践、照护和研究产生不可预知的影响。
- 该概念化从可观察的行为和神经发育障碍转向难以客观测量的内在体验障碍,包含许多模糊主观概念。
- 作者建议采用更精确的定量描述和更客观的症状测量来定义临床ASD表型,并识别核心ASD亚型/内表型。
研究设计与样本
- 本文为观点文章(perspective article),比较ICD-11与DSM-5对孤独症谱系障碍(ASD)的概念化方式。
主要发现
- 与DSM-5相比,ICD-11允许高度多样的症状组合,导致ASD操作化定义偏向极端多样的画面,可能牺牲精确性。
- ICD-11的ASD概念化难以与其他精神障碍和孤独症样特质区分,临床实用性存疑。
- 该概念化从可观察的行为和神经发育障碍转向难以客观测量的内在体验障碍,包含许多模糊主观概念,导致不可证伪的诊断。
- 存在假阳性诊断、患病率进一步升高、ASD特异性服务可及性受限和治疗非特异性增加的危险。
- 研究方面,ASD特异性可能降低,进一步增加已很高的异质性,妨碍研究重复,限制对病因和生物学通路的理解,使精准医学更遥远。
临床怎么用
- ICD-11的ASD概念化可能增加假阳性诊断风险,临床需警惕与其他精神障碍及孤独症样特质的鉴别。
- 该概念化可能影响ASD特异性服务的可及性并增加治疗的非特异性,临床实践需关注这些潜在后果。
- 作者建议采用更精确的定量描述和更客观的症状测量来定义临床ASD表型,以改善诊断分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This perspective article compares and contrasts the conceptualization of Autism Spectrum Disorder (ASD) in ICD-11 and DSM-5. By guiding the user through the ICD-11 text, it is argued that, in contrast to DSM-5, ICD-11 allows a high variety in symptom combinations, which results in an operationalization of ASD that is in favor of an extreme diverse picture, yet possibly at the expense of precision, including unforeseeable effects on clinical practice, care, and research. The clinical utility is questionable as this conceptualization can hardly be differentiated from other mental disorders and autism-like traits. It moves away from an observable, behavioral, and neurodevelopmental disorder to a disorder of inner experience that can hardly be measured objectively. It contains many vague and subjective concepts that lead to non-falsifiable diagnoses. This bears a large danger of false positive diagnoses, of further increased prevalence rates, limitations of access to ASD-specific services and of increasing the non-specificity of treatments. For research, the hypothesis is that the specificity of ASD will be reduced and this will additional increase the already high heterogeneity with the effect that replication of studies will be hampered. This could limit our understanding of etiology and biological pathways of ASD and bears the risk that precision medicine, i.e., a targeted approach for individual treatment strategies based on precise diagnostic markers, is more far from becoming reality. Thus, a more precise, quantitative description and more objective measurement of symptoms are suggested that define the clinical ASD phenotype. Identification of core ASD subtypes/endophenotypes and a precise description of symptoms is the necessary next step to advance diagnostic classification systems. Therefore, employing a more finely grained, objective, clinical symptom characterization which is more relatable to neurobehavioral concepts is of central significance.
引用
- Kamp-Becker I. Autism spectrum disorder in ICD-11-a critical reflection of its possible impact on clinical practice and research. Mol Psychiatry. 2024. PMID: 38273107. doi:10.1038/s41380-023-02354-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。